uBiome, the Leader in Microbial Genomics, Launches New Research Study Allowing SmartGut …

Funded by Y Combinator, Andreessen Horowitz, and other leading investors, uBiome pioneered the field of microbial genomics starting in 2012. uBiome’s mission is to transform the science of the microbiome into useful products and services that improve people’s lives. Press Contacts Mary Lewis

SmartGut patients can now join a research study to learn about how diet and lifestyle factors relate to the microbiome and gut conditions like inflammatory bowel disease, irritable bowel syndrome, Crohn’s disease, ulcerative colitis, and related health conditions.

SAN FRANCISCO (PRWEB) February 06, 2018

uBiome, the leader in microbial genomics, has launched a new research study to better understand the link between the human gut microbiome and diet, lifestyle, and weight management in patients who have used its SmartGut™ medical test, available through healthcare providers.

“Our SmartGut provides valuable information to healthcare providers and patients. The data we have gathered since the launch of SmartGut has been invaluable in helping us more fully understand the human microbiome in the context of gut conditions,” said Zachary Apte, PhD, co-founder and CTO at uBiome. “We’re excited to see the results of this research as it relates to weight management and other lifestyle factors within this cohort.”

SmartGut, which must be prescribed by a healthcare provider, uses precision sequencing™ technology to identify microbes in a patient’s gut that might be affecting his or her gut conditions. SmartGut helps doctors better understand common conditions related to the gut, such as bloating, constipation, diarrhea and other symptoms of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease.

SmartGut samples are processed in uBiome’s CLIA-licensed and CAP-accredited laboratory in San Francisco, California. The College of American Pathologists, with more than 18,000 members, is the world’s leading organization of board-certified pathologists. Its goal is to serve patients, physicians, and the public by encouraging, promoting, and supporting excellence in pathology and laboratory medicine.

SmartGut is available through healthcare providers in the United States and Canada. SmartGut users can choose to participate in this research if desired, but participation is not mandatory in order to receive SmartGut test results.

For more information on SmartGut, eligibility criteria for this research study, and how to request a kit, please visit uBiome’s study page.

About uBiome

uBiome is the leading microbial genomics company. Funded by Y Combinator, Andreessen Horowitz, and other leading investors, uBiome pioneered the field of microbial genomics starting in 2012. uBiome’s mission is to transform the science of the microbiome into useful products and services that improve people’s lives.

Press Contacts

Mary Lewis

mary.lewis(at)ubiome(dot)com

Lelle Henrichsen

lelle.henrichsen(at)ubiome(dot)com

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/02/prweb15171721.htm

Related Posts:

Analysts Set 2U Inc (TWOU) PT at $72.89

2U logo 2U Inc (NASDAQ:TWOU) has been given an average recommendation of “Buy” by the thirteen ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong …

2U logo2U Inc (NASDAQ:TWOU) has been given an average recommendation of “Buy” by the thirteen ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $72.89.

TWOU has been the topic of a number of recent analyst reports. Citigroup raised their target price on shares of 2U from $57.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 20th. Zacks Investment Research raised shares of 2U from a “hold” rating to a “buy” rating and set a $71.00 price target on the stock in a research note on Friday, January 12th. Credit Suisse Group reissued an “outperform” rating and set a $70.00 price target (up from $64.00) on shares of 2U in a research note on Wednesday, November 8th. Barrington Research reissued an “outperform” rating and set a $70.00 price target on shares of 2U in a research note on Wednesday, November 8th. Finally, BMO Capital Markets reissued a “buy” rating and set a $68.00 price target on shares of 2U in a research note on Wednesday, October 25th.

Shares of 2U (NASDAQ:TWOU) traded down $1.12 on Friday, reaching $67.98. 136,044 shares of the company were exchanged, compared to its average volume of 326,700. The stock has a market capitalization of $3,786.12, a P/E ratio of -103.13 and a beta of -0.05. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.48 and a quick ratio of 3.48. 2U has a 1-year low of $32.81 and a 1-year high of $76.50.

2U (NASDAQ:TWOU) last announced its earnings results on Tuesday, November 7th. The software maker reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01. The business had revenue of $70.25 million for the quarter, compared to the consensus estimate of $69.36 million. 2U had a negative net margin of 12.49% and a negative return on equity of 13.02%. 2U’s quarterly revenue was up 35.1% on a year-over-year basis. During the same period last year, the firm posted ($0.06) earnings per share. research analysts anticipate that 2U will post -0.6 EPS for the current year.

In other news, Director Paul A. Maeder bought 67,830 shares of the business’s stock in a transaction dated Thursday, December 7th. The shares were purchased at an average price of $61.45 per share, for a total transaction of $4,168,153.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Christopher J. Paucek sold 145,220 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $63.83, for a total transaction of $9,269,392.60. The disclosure for this sale can be found here. Insiders sold 181,923 shares of company stock worth $11,588,620 in the last 90 days. Company insiders own 8.40% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Bamco Inc. NY boosted its holdings in 2U by 334.0% in the third quarter. Bamco Inc. NY now owns 2,311,371 shares of the software maker’s stock valued at $129,529,000 after acquiring an additional 1,778,783 shares in the last quarter. American International Group Inc. boosted its holdings in 2U by 8.1% in the third quarter. American International Group Inc. now owns 29,364 shares of the software maker’s stock valued at $1,646,000 after acquiring an additional 2,196 shares in the last quarter. Allianz Asset Management GmbH boosted its holdings in 2U by 64.0% in the third quarter. Allianz Asset Management GmbH now owns 27,722 shares of the software maker’s stock valued at $1,554,000 after acquiring an additional 10,821 shares in the last quarter. BlackRock Inc. boosted its holdings in 2U by 13.3% in the second quarter. BlackRock Inc. now owns 2,628,814 shares of the software maker’s stock valued at $123,344,000 after acquiring an additional 308,339 shares in the last quarter. Finally, Bank of Nova Scotia bought a new stake in 2U in the second quarter valued at $1,441,000.

TRADEMARK VIOLATION WARNING: “Analysts Set 2U Inc (TWOU) PT at $72.89” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/06/analysts-set-2u-inc-twou-pt-at-72-89.html.

About 2U

2U, Inc is a provider of an integrated solution consisting of cloud-based software-as-a-service (SaaS) combined with technology-enabled services (together, the Platform) that allows colleges and universities to deliver online degree programs. The Company’s SaaS technology consists of a learning environment (Online Campus), which acts as the hub for all student and faculty academic and social interaction, and a suite of integrated applications, which the Company uses to launch, operate and support the Company’s clients’ programs.

Analyst Recommendations for 2U (NASDAQ:TWOU)

Receive News & Ratings for 2U Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for 2U and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

GeoCoin (GEO) Price Reaches $4.15 on Major Exchanges

GeoCoin can be purchased on these cryptocurrency exchanges: Cryptopia, Bittrex and YoBit. It is not currently possible to buy GeoCoin directly using U.S. dollars. Investors seeking to trade GeoCoin must first buy Bitcoin or Ethereum using an exchange that deals in U.S. dollars such as Coinbase, …

GeoCoin logoGeoCoin (CURRENCY:GEO) traded flat against the US dollar during the 1-day period ending at 12:00 PM E.T. on February 6th. During the last week, GeoCoin has traded down 18.2% against the US dollar. GeoCoin has a market capitalization of $14.14 million and approximately $0.00 worth of GeoCoin was traded on exchanges in the last 24 hours. One GeoCoin coin can currently be bought for approximately $4.15 or 0.00037462 BTC on exchanges including YoBit, Cryptopia and Bittrex.

Here’s how other cryptocurrencies have performed during the last 24 hours:

  • Auroracoin (AUR) traded 16.7% higher against the dollar and now trades at $1.55 or 0.00021765 BTC.
  • FlorinCoin (FLO) traded down 4% against the dollar and now trades at $0.0764 or 0.00001074 BTC.
  • FedoraCoin (TIPS) traded 0.4% lower against the dollar and now trades at $0.0000 or 0.00000000 BTC.
  • HollyWoodCoin (HWC) traded 3.7% higher against the dollar and now trades at $5.70 or 0.00080100 BTC.
  • Fastcoin (FST) traded 9.7% higher against the dollar and now trades at $0.0101 or 0.00000142 BTC.
  • Tychocoin (TYCHO) traded down 7.9% against the dollar and now trades at $0.0221 or 0.00000311 BTC.

About GeoCoin

GeoCoin (GEO) is a coin. GeoCoin’s total supply is 3,406,438 coins. GeoCoin’s official website is geocoin.cash. GeoCoin’s official Twitter account is @geo_coin.

According to CryptoCompare, “GeoCoins are simple, geocaching-themed, virtual “coins.” They are designed to be easy to create, easy to collect and easy to share with your friends! At their most simple, GeoCoins will allow you to send and receive virtual GeoCoins encoded with short personal messages.On the technical side of things, cryptographic proof-of-work provides a real-time peer to peer network of transaction verification, a “public ledger” of synchronized numbers, and unique possibilities for math-based puzzles. “

GeoCoin Coin Trading

GeoCoin can be purchased on these cryptocurrency exchanges: Cryptopia, Bittrex and YoBit. It is not currently possible to buy GeoCoin directly using U.S. dollars. Investors seeking to trade GeoCoin must first buy Bitcoin or Ethereum using an exchange that deals in U.S. dollars such as Coinbase, Changelly or Gemini. Investors can then use their newly-acquired Bitcoin or Ethereum to buy GeoCoin using one of the exchanges listed above.

Receive News & Updates for GeoCoin Daily – Enter your email address below to receive a concise daily summary of the latest news and updates for GeoCoin and related cryptocurrencies with MarketBeat.com’s FREE CryptoBeat newsletter.

Related Posts:

  • No Related Posts

Paul Milgrom to Receive CME Group-MSRI Prize in Innovative Quantitative Applications

CHICAGO, Feb. 6, 2018 /PRNewswire/ — CME Group, the world’s leading and most diverse derivatives marketplace, and the Mathematical Sciences Research Institute (MSRI) announced Paul Milgrom, Shirley and Leonard Ely Professor of Humanities and Sciences in the Department of Economics at …

Past CME Group-MSRI Prize winners have included distinguished luminaries in economics and mathematics. Five out of 10 of these past recipients have gone on to receive the Nobel Prize in Economic Sciences. A complete list of past recipients is available at cmegroup.com.

The CME Group-MSRI Prize recognizes individuals who contribute original concepts in mathematical, statistical or computational methods for the study of the markets’ behavior and global economics. Milgrom has done extensive research on this year’s panel topic. He is best known for his contributions to microeconomic theory, his pioneering innovations in the practical design of multi-item auctions, and the extraordinary successes of his students and academic advisees.

“I am honored to be able to accept this prize for myself and to honor my collaborators, who have helped me both to conduct my most important research and to bring my ideas to practice,” said Milgrom. “Bob Wilson, who won this prize last year, was my teacher who guided my first research efforts and collaborated with me on my first real-world auction design. Another past winner, Dave Kreps, was also an early collaborator, as was Nobel laureate Bengt Holmstrom. It is hard to go wrong with collaborators like those! Or like Evan Kwerel, Ilya Segal, Kevin Leyton-Brown, John Roberts, Robert Weber, Larry Glosten and Nancy Stokey, all of whom played crucial roles in bringing our work to fruition.”

Milgrom is a member of the National Academy of Sciences and the American Academy of Arts and Sciences, and winner of the 2008 Nemmers Prize in Economics and the 2012 BBVA Frontiers of Knowledge award.

“Professor Paul Milgrom’s groundbreaking work in game theory, auction theory and market design is invaluable to the financial industry and to the field of economics,” said Leo Melamed, Chairman Emeritus of CME Group and founder of the CME Group-MSRI Prize in Innovative Quantitative Applications. “We applaud his selection for this prestigious award.”

“Thirty years ago, abstract topological concepts were important in establishing the existence of equilibria – but today, deep mathematical tools from finite mathematics such as matching theory, discrete optimization and matroids are being applied to concrete problems from kidney exchanges to auction design,” said David Eisenbud, Director of MSRI and Professor of Mathematics at the University of California, Berkeley. “No one embodies the utility and success of these methods better than Paul Milgrom.”

The panel discussion, which will focus on topics related to research on financial market design, will precede the award ceremony. Several distinguished economists and academics will be participating in the panel, including:

  • Preston McAfee, Moderator, Chief Economist, Microsoft Corporation
  • Mohammad Akbarpour, Assistant Professor of Economics, Graduate School of Business, Stanford University
  • Piotr Dworczak, Assistant Professor, Department of Economics, University of Chicago
  • Shengwu Li, Junior Fellow of the Society of Fellows, Department of Economics, Harvard University
  • Ellen Muir, Research Fellow, School of Mathematics & Statistics, The University of Melbourne

Members of the media can attend the award ceremony where CME Group will present Milgrom with the CME Group-MSRI Prize medal and $50,000 cash award. Email Liz Mannebach at liz.mannebach@cmegroup.com to register.

The CME Center for Innovation’s mission is to identify, foster and showcase examples of significant innovation and creative thinking pertaining to markets, commerce or trade in the public and private sectors. For more information on the CME Center for Innovation, visit http://www.cmegroup.com/company/center-for-innovation/.

About MSRI

The Mathematical Sciences Research Institute (MSRI) in Berkeley, California, is one of the world’s preeminent centers for collaborative research in the mathematical sciences. MSRI advances mathematical research through workshops and conferences since its founding in 1982, and over 1,700 mathematicians are hosted by MSRI each year. A rotating committee of renowned mathematical scientists governs the Institute’s scientific program with a vision of the field that is perpetually renewed. A Board of Trustees, composed of accomplished business and academic leaders, oversees the Institute’s strategy, and assures its operational and financial welfare. The Institute has been funded primarily by the National Science Foundation with additional support from other government agencies, private foundations, corporations, individual donors, and nearly 100 academic institutions.

MSRI also serves a wider community through the development of human scientific capital, providing postdoctoral training to extraordinary young scientists and increasing the diversity of the research workforce. The Institute advances the education of young people with conferences on critical issues in mathematics education. MSRI has created a national “math circles” movement of small organizations teaching and engaging children in math as a hobby, beyond the standard curricula. MSRI strives to make mathematics accessible and exciting to those outside the field through film production and public programs, including the National Math Festival in Washington, D.C. and the Mathical: Books for Kids from Tots to Teens youth book prize. For more information, visit www.msri.org.

About CME Group

As the world’s leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. Around the world, CME Group brings buyers and sellers together through its CME Globex® electronic trading platform. CME Group also operates one of the world’s leading central counterparty clearing providers through CME Clearing, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. CME Group’s products and services ensure that businesses around the world can effectively manage risk and achieve growth.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT, Chicago Board of Trade, KCBT and Kansas City Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor’s Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners.

CME-G

Cision View original content:http://www.prnewswire.com/news-releases/paul-milgrom-to-receive-cme-group-msri-prize-in-innovative-quantitative-applications-300594358.html

SOURCE CME Group

Related Links

http://www.cmegroup.com

Related Posts:

  • No Related Posts

Why Cboe Global Markets, Inc. Stock Is Sinking Today

Shares of Cboe Global Markets, Inc. (NASDAQ:CBOE) are falling today, down by about 12% as of 11:30 a.m. EST. Investors are worried about how the failure of some products designed to short the VIX index will affect Cboe Global Market’s VIX-related volume, revenue, and ultimately, its earnings.

What happened

Shares of Cboe Global Markets, Inc.(NASDAQ:CBOE) are falling today, down by about 12% as of 11:30 a.m. EST. Investors are worried about how the failure of some products designed to short the VIX index will affect Cboe Global Market’s VIX-related volume, revenue, and ultimately, its earnings.

So what

Cboe Global Markets provides the exchanges on which buyers and sellers of options, futures, and other derivatives meet. In recent years, its growth has been fueled by complex products, including VIX index futures and options, which allow traders to bet on whether markets will become more or less volatile. The VIX is often referred to as the “fear gauge,” since it measures implied volatility of S&P 500 stock prices based on how much investors are willing to pay for options to hedge their risks.

Line chart of stock prices

Image source: Getty Images.

A research report by KBW published on Tuesday estimated that as much as 20% to 25% of Cboe Global Market’s revenue was generated from products related to the VIX, according to Business Insider. Much of that volume and related revenue could dry up, however, as exchange-traded notes (ETNs) linked to the VIX index are shuttering their doors.

For a long time, shorting the VIX was a profitable trade. In the five years leading up to market close yesterday, the VelocityShares Daily Inverse VIX Short-Term ETN(NASDAQ:XIV) generated a compounded annual return of 35.7%, easily outpacing the stock market average. Many investors hopped on for the ride, viewing this ETN and others like it as a way to make a highly leveraged bet that stock prices would go up and up, and with little volatility along the way.

XIV Chart

XIV data by YCharts.

But as many people found out yesterday, there are no risk-free ways to make exceptionally high returns. The VelocityShares Daily Inverse VIX Short-Term ETN saw its net asset value plunge from more than $108 to $4.22 per share in a single day due to a spike in volatility. Its sponsor, Credit Suisse, says it will fold up the ETN, liquidate it, and make a cash payment to its owners, locking in losses for those who hold it. (The chart above doesn’t fully reflect the decline in VelocityShares ETN’s value, since trading is currently halted.)

Now what

Between the VelocityShares Daily Inverse VIX Short-Term ETN and ProShares Short VIX Short-Term Futures ETF(NYSEMKT:SVXY), as much as $3 billion of investors’ wealth could have simply evaporated in a single day of trading thanks to a massive, one-day surge in the VIX.

Cboe Global Markets, which derives a portion of its revenue from volatility-related trading, will naturally see revenue from ETF and ETNs that short the VIX dry up, as investors turn away from the strategy in light of large losses. Importantly, many of the people who held ETNs and ETFs that short the VIX were retail investors who wouldn’t otherwise speculate on the VIX if not for the fact that ETFs and ETNs made the strategy available to them. These retail speculators are unlikely to move from ETFs and ETNs to trade VIX futures or options directly.

To be clear, this isn’t a failure of Cboe. Markets simply went the wrong way for the people who held ETFs and ETNs that were short the VIX. That said, a decline in VIX-related volumes could be a short-term headwind for the exchange operator, as it has benefited indirectly from large bets against market volatility.

Related Posts:

  • No Related Posts